secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2026-04-10T23:59:59+00:00
Accession:  0001193125-26-151259
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences reclassifies director Ilan Ganot from Class III to Class I to balance board composition
--------------------------------------------------------------------------------

- Ilan Ganot resigned from Class III effective 4:00 p.m. ET on April 10, 2026.
- Board reduced Class III to three directors and increased Class I to three, appointing Ganot to Class I with term expiring at 2028 Annual Meeting.
- Ganot's compensation arrangements unchanged; no compensation due for resignation or appointment.
- Company will seek advisory ratification of Ganot's appointment as Class I Director at 2026 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526151259/0001193125-26-151259-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526151259/sldb-20260410.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-151259

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer